1. Market Research
  2. > Biotechnology Market Trends
  3. > Biotechnology Analysis & Statistics, November 2016 (p40)

Biotechnology Analysis & Statistics, November 2016 (p40)

24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Publishers

All regions

1171-1200 of about 3300 reports

Purchase Reports From Reputable Market Research Publishers

Hepatitis B - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Hepatitis B - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis B - Pipeline Review, H2 2016, provides an overview of the ...

  • Industries : Pathology, Healthcare, Therapy, Pharmaceutical
  • Countries : United States, World

National Human Genome Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2016
  • by GlobalData

Summary National Human Genome Research Institute (NHGRI) a subsidiary of National Institutes of Health is a research institute that provides human genome researches. The institute offers research programs ...

  • Industries : Genomics

Sirion Biotech GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2016
  • by GlobalData

Summary Sirion Biotech GmbH (Sirion Biotech) is a biotechnology company that supplies viral vector technologies for various gene therapy applications. The company offers various platforms including adenovirus, ...

  • Industries : Biotechnology

Fanconi Anemia - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Fanconi Anemia - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Fanconi Anemia - Pipeline Review, H2 2016, provides an overview of ...

  • Industries : Pathology
  • Countries : United States, World

Polyarticular Juvenile Idiopathic Arthritis (PJIA) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Polyarticular Juvenile Idiopathic Arthritis (PJIA) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Polyarticular Juvenile Idiopathic ...

  • Industries : Chronic Disease, Pathology, Therapy, Pharmaceutical, Biopharmaceutical
  • Countries : United States

Metastatic Colorectal Cancer - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Metastatic Colorectal Cancer - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Metastatic Colorectal Cancer – Pipeline Review, H2 ...

  • Industries : Cancer, Pathology
  • Countries : United States

Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha (CDw116 or CD116 or CSF2RA) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha (CDw116 or CD116 or CSF2RA) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Granulocyte Macrophage Colony Stimulating ...

  • Industries : Therapy, Biological Therapy, Pharmaceutical
  • Countries : United States

Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin ...

  • Industries : Biopharmaceutical, Therapy
  • Countries : United States, World

Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) - Pipeline Review, H2 2016 Summary Global Markets ...

  • Industries : Therapy, Cancer, Pathology
  • Countries : United States

HIV 1 Integrase (EC 2.7.7.) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

HIV 1 Integrase (EC 2.7.7.) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘HIV 1 Integrase (EC 2.7.7.) - Pipeline Review, H2 2016’, provides in depth analysis on HIV 1 Integrase (EC ...

  • Industries : Therapy
  • Countries : United States

Neuroblastoma - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Neuroblastoma - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neuroblastoma – Pipeline Review, H2 2016, provides an overview of ...

  • Industries : Cancer, Pathology
  • Countries : United States

Shin Nippon Biomedical Laboratories Ltd (2395) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2016
  • by GlobalData

Summary Shin Nippon Biomedical Laboratories Ltd (SNBL) is a healthcare service provider that provides drug and clinical development service to biopharmaceutical companies. Its preclinical services include ...

  • Industries : Biopharmaceutical, Pharmaceutical
  • Countries : Japan

Kythera Biopharmaceuticals Inc (KYTH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2016
  • by GlobalData

Summary Kythera Biopharmaceuticals Inc (Kythera), a subsidiary of Allergan Plc is a clinical-stage biopharmaceutical company that discovers, develops and commercializes medical aesthetics products. The ...

  • Industries : Biopharmaceutical
  • Countries : United States

Biosurgery Market by Product Application - Forecast to 2021

  • $ 5650
  • Industry report
  • November 2016
  • by MarketsandMarkets

The “BIOSURGERY MARKET BY PRODUCT (FIBRIN & COLLAGEN SEALANT, HEMOSTATS, ADHESION BARRIERS, BIOLOGICAL MESHS, SOFT TISSUE ATTACHMENTS, STAPLER, BONE GRAFT SUBSTITUES) BY APPLICATION (ORTHOPEDIC, GYNECOLOGY, ...

  • Industries : Health Services, Healthcare, Chemical, Specialty Chemical
  • Countries : World, Europe

Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) ...

  • Industries : Therapy, Health Services, Pathology, Healthcare
  • Countries : United States

Ocimum Biosolutions Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2016
  • by GlobalData

Summary Ocimum Biosolutions Ltd (Ocimum) is a life science informatics company that provides solutions with data analysis services and Bio-IT consulting services. The company offers bio- analytics, genomics ...

  • Industries : Genomics

Orega Biotech SAS - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2016
  • by GlobalData

Summary Orega Biotech SAS (Orega Biotech) is a pharmaceutical company that focuses on the development of monoclonal antibodies for cancer immunotherapy. Its product portfolio includes anti-CD39 mAbs and ...

Sino Biopharmaceutical Ltd (1177) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2016
  • by GlobalData

Summary Sino Biopharmaceutical Ltd (Sino) is a pharmaceutical company that develops, manufactures and markets Chinese medicines and chemical medicines. The company’s products include kaishi (alprostadil) ...

  • Industries : Pharmaceutical

Oncology drug report - Herceptin - trastuzumab - 2006-2015 analysis; 2016-2021 expectations

  • $ 300
  • Industry report
  • November 2016
  • by Cancer Research Analytics

“Herceptin (trastuzumab): 2006-2015 analysis; 2016-2021 expectations” is a comprehensive report on the second-largest oncology drug by 2015 sales. Herceptin falls in the monoclonal antibody, HER2 inhibitor, ...

  • Industries : Therapy, Oncology
  • Countries : Europe, Japan, World

Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Lymphocytic Leukemia (CLL) – Pipeline ...

  • Industries : Cancer, Pathology
  • Countries : United States

Minerva Biotechnologies Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2016
  • by GlobalData

Summary Minerva Biotechnologies Corp (Minerva) is a biotechnology company that develops immunotherapies and cancer drugs that aim solid tumours and prevents cancer metastasis. It discovered that cance ...

  • Industries : Biotechnology

MP Biomedicals LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2016
  • by GlobalData

Summary MP Biomedicals LLC (MP Biomedicals), formerly ICN Biomedicals is a diagnostic company that manufactures and markets life science, fine chemical and diagnostic products. Its life science products ...

Scarab Genomics LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2016
  • by GlobalData

Summary Scarab Genomics LLC (Scarab Genomics) is a biotechnology company that developsbio-engineered materials. The company’s products include modified korz medium kit, modified korz medium with glucose ...

  • Industries : Genomics

Novozymes – Patalganga Enzyme Production Plant – Maharashtra - Construction Project Profile

  • $ 75
  • Company report
  • November 2016
  • by Timetric

Synopsis "Novozymes – Patalganga Enzyme Production Plant – Maharashtra - Construction Project Profile" contains information on the scope of the project including project overview and location. The ...

  • Industries : Construction, Biopharmaceutical
  • Countries : India

Myelodysplastic Syndrome - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Myelodysplastic Syndrome - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myelodysplastic Syndrome – Pipeline Review, H2 2016, provides ...

  • Industries : Cancer, Pathology
  • Countries : United States

Eosinophilic Esophagitis Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • November 2016
  • by GlobalData

Eosinophilic Esophagitis Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Eosinophilic Esophagitis Global Clinical Trials Review, H2, 2016" provides an overview of ...

  • Industries : Therapy, Pathology, Pharmaceutical, Healthcare
  • Countries : World

Liver Fibrosis Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • November 2016
  • by GlobalData

Liver Fibrosis Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Liver Fibrosis Global Clinical Trials Review, H2, 2016" provides an overview of Liver Fibrosis clinical ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Therapy
  • Countries : World

Liver Cirrhosis Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • November 2016
  • by GlobalData

Liver Cirrhosis Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Liver Cirrhosis Global Clinical Trials Review, H2, 2016" provides an overview of Liver Cirrhosis clinical ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Pathology, Therapy, Healthcare
  • Countries : World

Fatigue Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • November 2016
  • by GlobalData

Fatigue Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Fatigue Global Clinical Trials Review, H2, 2016" provides an overview of Fatigue clinical trials scenario. ...

  • Industries : Therapy, Pharmaceutical
  • Countries : World

Uveitis Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • November 2016
  • by GlobalData

Uveitis Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Uveitis Global Clinical Trials Review, H2, 2016" provides an overview of Uveitis clinical trials scenario. ...

  • Industries : Therapy, Drug Discovery and Development, Pharmaceutical
  • Countries : World

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.